NCT05852795

Brief Summary

Mindfulness is a technique that involves the intentional and non-judgmental regulation of attention to the present moment, with curiosity, openness, and acceptance, as per its definition. Mindfulness-based interventions (MBIs) have been used to manage mood disorders in various clinical and non-clinical settings, including neurological patients and cardiovascular diseases. Studies have consistently demonstrated that MBIs reduce depressive and anxiety symptoms, as well as rumination. MBIs are considered an alternative and effective treatment for reducing psychological stress in the management of different health conditions. Virtual reality (VR) has recently been proposed as an intermediate interface to help patients with emotional dysregulation learn mindfulness practices. Within this context, new approaches to mental health integrating advanced technologies such as VR can play a critical role. In this interventional study we will seek to demonstrate the effectiveness of a virtual reality-mediated mindfulness-based intervention in a particular group of people who are constantly experiencing psychological distress due to caring for children with autism spectrum disorders (ASD).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2023

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2023

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

April 24, 2023

Completed
16 days until next milestone

First Posted

Study publicly available on registry

May 10, 2023

Completed
Last Updated

May 10, 2023

Status Verified

May 1, 2023

Enrollment Period

10 months

First QC Date

April 24, 2023

Last Update Submit

May 9, 2023

Conditions

Keywords

AutismParentsVirtual RealityMental healthMindfulnessParental wellbeing

Outcome Measures

Primary Outcomes (4)

  • Parental Stress Index/Short Form (PSI/SF)

    The Parenting Stress Index/Short Form (PSI/SF) is a self-administered questionnaire that aims to identify factors that may negatively impact a child's development

    The test needs approximately 10 minutes to complete

  • Mindful Attention Awareness Scale (MAAS)

    The Mindful Attention Awareness Scale (MAAS) consists of 15 items, each scored on a Likert scale ranging from 1 (almost always) to 6 (almost never). The total score on the MAAS ranges from a minimum of 15 (reflecting a response of 1 on all items) to a maximum of 90 (reflecting a response of 6 on all items). Higher scores on the MAAS indicate greater clinical improvement in a patient's capacity for present moment awareness.

    The test needs approximately 10 minutes to complete

  • State-Trait Anxiety Inventory (STAI)

    The total State-Trait Anxiety Inventory (STAI) score is between 20 and 80 with a predictive threshold value of anxious symptomatology set at 40. The level of severity can also be defined according to a scalar criterion: from 40 to 50 mild form, from 50 to 60 moderate, \> of 60 serious.

    The test needs approximately 10 minutes to complete

  • Beck Depression Inventory (BDI)

    The Beck Depression Inventory is a depression rating scale that can be used with individuals 13 years of age and older and assesses symptoms of depression on a scale of 0 to 3 based on 21 specific items.

    The test needs approximately 10 minutes to complete

Secondary Outcomes (2)

  • Heart rate (HR)

    The test needs approximately 30 minutes

  • Heart rate variability (HRV)

    The test needs approximately 30 minutes

Study Arms (2)

Experimental group

EXPERIMENTAL

VR-based and audio-based mindfulness experience. Partecipants watch VR scenario and receive a guided mindfulness practice.

Other: Virtual Reality-mediated Mindfulness-Based Interventions

Control Group

OTHER

VR-based mindfulness experience. Participants watch VR scenario without experiencing voice guided mindfulness practice.

Other: Virtual Reality-mediated Mindfulness-Based Interventions without audio guided experience

Interventions

The Experimental will undergo 8 weekly sessions of immersive experience lasting 30 minutes. Each session is divided as follows: * First phase: Detection of physiological parameters with Oculus equipment switched off (10 minutes). * Second phase: Detection of physiological parameters with Oculus instrumentation turned ON during mindfulness experience (10 minutes * Third phase: Detection of physiological parameters with Oculus equipment switched off (10 minutes). This intervention will produce a multisensory experience merging visual and digital auditory stimuli. The audio recording also included some ambient natural sound effects, to make the practice more immersive.

Experimental group

The Control will undergo 8 weekly sessions of immersive experience lasting 30 minutes. Each session is divided as follows: * First phase: Detection of physiological parameters with Oculus equipment switched off (10 minutes). * Second phase: Detection of physiological parameters with Oculus instrumentation turned ON during mindfulness experience (10 minutes * Third phase: Detection of physiological parameters with Oculus equipment switched off (10 minutes). This intervention will produce a monosensorial experience with video guided stimulation of naturalistic scenarios.

Control Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • being parent of a child diagnosed with autism
  • absence of pharmacotherapy that could interfere with the measured data (psychoactive drugs, anti-hypertensive, anti-depressants)
  • no significant visual impairment

You may not qualify if:

  • history of psychiatric diagnosis
  • presence of medical disorders (heart disease or blood pressure, neurological disorders, epilepsy)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute for Biomedical Research and Innovation (IRIB) - National Research Council (CNR)

Messina, 98164, Italy

Location

Related Publications (3)

  • Failla C, Marino F, Bernardelli L, Gaggioli A, Doria G, Chila P, Minutoli R, Mangano R, Torrisi R, Tartarisco G, Bruschetta R, Arcuri F, Cerasa A, Pioggia G. Mediating Mindfulness-Based Interventions with Virtual Reality in Non-Clinical Populations: The State-of-the-Art. Healthcare (Basel). 2022 Jun 29;10(7):1220. doi: 10.3390/healthcare10071220.

    PMID: 35885747BACKGROUND
  • Puglisi A, Capri T, Pignolo L, Gismondo S, Chila P, Minutoli R, Marino F, Failla C, Arnao AA, Tartarisco G, Cerasa A, Pioggia G. Social Humanoid Robots for Children with Autism Spectrum Disorders: A Review of Modalities, Indications, and Pitfalls. Children (Basel). 2022 Jun 25;9(7):953. doi: 10.3390/children9070953.

    PMID: 35883937BACKGROUND
  • Marino F, Failla C, Carrozza C, Ciminata M, Chila P, Minutoli R, Genovese S, Puglisi A, Arnao AA, Tartarisco G, Corpina F, Gangemi S, Ruta L, Cerasa A, Vagni D, Pioggia G. Mindfulness-Based Interventions for Physical and Psychological Wellbeing in Cardiovascular Diseases: A Systematic Review and Meta-Analysis. Brain Sci. 2021 May 29;11(6):727. doi: 10.3390/brainsci11060727.

    PMID: 34072605BACKGROUND

MeSH Terms

Conditions

Autism Spectrum DisorderAutistic DisorderPsychological Well-Being

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental DisordersPersonal SatisfactionBehavior

Study Officials

  • Antonio Cerasa

    antonio.cerasa@irib.cnr.it

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Unit

Study Record Dates

First Submitted

April 24, 2023

First Posted

May 10, 2023

Study Start

June 1, 2022

Primary Completion

April 1, 2023

Study Completion

April 15, 2023

Last Updated

May 10, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations